Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
Source:
cnbc
September 30, 2026 · 07:15
From the publisher
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
The original article opens on the publisher's website.
More from General
View topic →We’re introducing SynthID Bio, bringing our watermarking technology to synthetic biology.
googleBlog
Sep 30, 2026 · 08:00
How Trump keeps undercutting his anti-communist message
nprNews
Sep 30, 2026 · 07:58
Crypto Long & Short: What will the AI agents run on?
coinDesk
Sep 30, 2026 · 07:56
More than 44,000 file legal objections to Palantir NHS platform handling their data
guardianTech
Sep 30, 2026 · 07:51
Pledge signed by President Trump and top AI leaders misspells the United States
techcrunch
Sep 30, 2026 · 07:50